Members

Anatomie-onderwijs voor de zorgprofessional van morgen. Een anatomische e-learningapplicatie met fotorealistische inhoud, waarin kennisoverdracht en toetsing op een intuïtieve, persoonlijke en aantrekkelijke manier op elke plaats en op elk moment kunnen plaatsvinden.

EV Biotech combines cutting-edge AI with deep fermentation expertise to design, optimize, and scale microbial production strains. Through our proprietary ArtemisAI platform, we co-develop bio-based products with partners — from early strain engineering to industrial-scale readiness. Whether you’re launching a novel ingredient or improving an existing process, we turn your vision into a scalable, commercially viable reality.

Griphingo Pharmaceuticals is a University of Groningen spin-off that aims to improve the quality of life of thousands of patients with chronic obstructive pulmonary disease (COPD), by local administration of their proprietary lead compound. COPD is a chronic, progressive and ultimately fatal disease, for which currently no adequate therapy is available. Griphingo’s invention reduces pulmonary inflammation and fibrosis. The disease-modifying approach has first-in-class potential in restoring lung function. The observed positive effects are connected to a decrease in neutrophil influx in the lungs as a result of a decrease in IL-8. The effects are also associated with the restoration of the expression of the anti-inflammatory cytokine IL-10 and a reduction in fibronectin. Research on COPD is traditionally strong in the University of Groningen and the University Medical Centre Groningen. Griphingo Pharmaceuticals’ development of molecules for COPD treatment capitalizes on this local strength. Their team and partner network is poised to continue with the pre-clinical studies to progress their lead compound to a Phase I clinical trial. This should provide a steppingstone for future clinical trials to bring our novel inhalation therapy for COPD patients closer to practice.

H&P Moulding is a full-service, turnkey manufacturer of plastic injection-moulded parts. With over 30 years’ experience in the industry, we offer comprehensive mould design services from concept to completion, high-quality plastic injection-moulded products, as well as packaging and delivery.

Wij zijn een wereldwijde aanbieder van adviesdiensten en uitbestede ontwikkelings- en commercialiseringsdiensten aan farmaceutische bedrijven, biotechnologiebedrijven, fabrikanten van medische hulpmiddelen en overheids- en volksgezondheidsorganisaties. Wij richten onze innovatie op de factoren die voor onze klanten van cruciaal belang zijn – het verkorten van de time-to-market, het verlagen van de kosten en het verhogen van de kwaliteit – en ons wereldwijde team van experts beschikt over uitgebreide ervaring in een breed scala aan therapeutische gebieden. Wij streven ernaar om als betrouwbare partner te fungeren en onze klanten te begeleiden door het steeds veranderende landschap van klinische ontwikkeling, zodat zij hun bedrijfsdoelstellingen beter kunnen realiseren.

IMDS (International Medical Device Solutions) is dedicated to improve the patient outcome of percutaneous coronary interventions (PCI). With strong focus on game changing in-house technology we develop unique solutions enabling advanced treatment options. All of our manufacturing is performed in our Roden, The Netherlands, based facility. This enables end-to-end quality control and seamless transition from idea to final product.

Implican develops a surgical device for use in colorectal anastomoses procedures. Our patented technology is aiming at improved medical outcomes by reducing the risk of anastomotic leakage.We are dedicated to launch a sustainable re-usable device to facilitate the reduction of hospital waste.Implican believes in a profitable circular business model while also reducing society health care costs.

InnoCore is the partner of choice to the global pharma and biotech industry for developing long-acting injectable peptide and biologic therapeutics to improve the lives of patients. We are a global leader in bioresorbable polymer based parenteral dosage forms and experts in formulating peptides and complex biologics into scalable long-acting injectable (LAI) dosage forms with customized pharmacokinetics.